Bob Rai - AVRICORE HEALTH CEO, Director

8VP1 Stock  EUR 0.1  0.02  19.02%   

CEO

Mr. Bob Rai serves as Chief Executive Officer, Director of Vanc Pharmaceuticals Inc. Mr. Rai is a graduate of the University of British Columbia with BS Degrees in Biochemistry and Pharmaceutical Science. Mr. Rai recently operated a chain of The Medicine Shoppe Pharmacies in Greater Vancouver for the past 21 years, he has had several successful entrepreneurial and charitable endeavors. In 1998 Mr. Rai and his partners pioneered and revolutionized the online pharmacy business to the United States. The online sales and distribution of prescription medicines saw unprecedented industry growth and as other operators followed suit, the unique business concept became a billion dollar industry across Canada since 2017.
Tenure 7 years
Phone604-247-2639
Webhttp://www.avricorehealth.com
Rai is also Chairman and CEO of Canada Pacific Global Pharmaceuticals and Chairman of its subsidiary, PharmaCanada Inc. He has served as President of the Philippines Canada Trade Council from 20062007 and held the position of VicePresident from 20042006. As President of PCTC, he led a successful Trade Mission to Manila with endorsements from His Excellency Canadian Prime Minister Stephen Harper, Honorable Premier Gordon Campbell of British Columbia and Minister of International Trade and Industry of Canada David Emerson. In 2013 Mr. Rai was the recipient of the Queen Diamond Jubilee Medal for his over 20 years of community and volunteer work. He is also the recipient of the National Professional Achievement Award as a Pharmacist

AVRICORE HEALTH Management Efficiency

The company has return on total asset (ROA) of (0.2745) % which means that it has lost $0.2745 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3844) %, meaning that it generated substantial loss on money invested by shareholders. AVRICORE HEALTH's management efficiency ratios could be used to measure how well AVRICORE HEALTH manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Found 2 records

CEO Age

Giovanni FerigoInfrastrutture Wireless Italian
58
Oscar CicchettiInfrastrutture Wireless Italian
65
Avricore Health Inc. manufactures and sells over-the-counter products in Canada. Avricore Health Inc. was founded in 1996 and is headquartered in Vancouver, Canada. AVRICORE HEALTH operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. AVRICORE HEALTH INC (8VP1) is traded on Frankfurt Exchange in Germany and employs 8 people.

Management Performance

AVRICORE HEALTH INC Leadership Team

Elected by the shareholders, the AVRICORE HEALTH's board of directors comprises two types of representatives: AVRICORE HEALTH inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AVRICORE. The board's role is to monitor AVRICORE HEALTH's management team and ensure that shareholders' interests are well served. AVRICORE HEALTH's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AVRICORE HEALTH's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Sindelar, Director
Kevin Strong, CFO
Sherif Guorgui, Director
Deena Siblock, Corporate Secretary
Bob Rai, CEO, Director
David Hall, Chairman of the Board
Alan Arnstein, Director
Zula Kropivnitski, CFO

AVRICORE Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AVRICORE HEALTH a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AVRICORE HEALTH in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AVRICORE HEALTH's short interest history, or implied volatility extrapolated from AVRICORE HEALTH options trading.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AVRICORE HEALTH INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for AVRICORE Stock analysis

When running AVRICORE HEALTH's price analysis, check to measure AVRICORE HEALTH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AVRICORE HEALTH is operating at the current time. Most of AVRICORE HEALTH's value examination focuses on studying past and present price action to predict the probability of AVRICORE HEALTH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AVRICORE HEALTH's price. Additionally, you may evaluate how the addition of AVRICORE HEALTH to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Please note, there is a significant difference between AVRICORE HEALTH's value and its price as these two are different measures arrived at by different means. Investors typically determine if AVRICORE HEALTH is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AVRICORE HEALTH's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.